Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
J Am Heart Assoc ; 7(17): e008981, 2018 09 04.
Artigo em Inglês | MEDLINE | ID: mdl-30371164

RESUMO

Background Advanced cardiac imaging permits optimal targeting of cardiac treatment but needs to be faster, cheaper, and easier for global delivery. We aimed to pilot rapid cardiac magnetic resonance ( CMR ) with contrast in a developing nation, embedding it within clinical care along with training and mentoring. Methods and Results A cross-sectional study of CMR delivery and clinical impact assessment performed 2016-2017 in an upper middle-income country. An International partnership (clinicians in Peru and collaborators from the United Kingdom, United States, Brazil, and Colombia) developed and tested a 15-minute CMR protocol in the United Kingdom, for cardiac volumes, function and scar, and delivered it with reporting combined with training, education and mentoring in 2 centers in the capital city, Lima, Peru, 100 patients referred by local doctors from 6 centers. Management changes related to the CMR were reviewed at 12 months. One-hundred scans were conducted in 98 patients with no complications. Final diagnoses were cardiomyopathy (hypertrophic, 26%; dilated, 22%; ischemic, 15%) and 12 other pathologies including tumors, congenital heart disease, iron overload, amyloidosis, genetic syndromes, vasculitis, thrombi, and valve disease. Scan cost was $150 USD, and the average scan duration was 18±7 minutes. Findings impacted management in 56% of patients, including previously unsuspected diagnoses in 19% and therapeutic management changes in 37%. Conclusions Advanced cardiac diagnostics, here CMR with contrast, is possible using existing infrastructure in the developing world in 18 minutes for $150, resulting in important changes in patient care.


Assuntos
Países em Desenvolvimento , Cardiopatias/diagnóstico por imagem , Imagem Cinética por Ressonância Magnética/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Amiloidose/diagnóstico por imagem , Amiloidose/terapia , Cardiomiopatias , Meios de Contraste , Estudos Transversais , Atenção à Saúde , Feminino , Custos de Cuidados de Saúde , Cardiopatias Congênitas/diagnóstico por imagem , Cardiopatias Congênitas/terapia , Cardiopatias/terapia , Neoplasias Cardíacas/diagnóstico por imagem , Neoplasias Cardíacas/terapia , Doenças das Valvas Cardíacas/diagnóstico por imagem , Doenças das Valvas Cardíacas/terapia , Humanos , Cooperação Internacional , Sobrecarga de Ferro/diagnóstico por imagem , Sobrecarga de Ferro/terapia , Imageamento por Ressonância Magnética/economia , Imageamento por Ressonância Magnética/métodos , Imagem Cinética por Ressonância Magnética/economia , Masculino , Pessoa de Meia-Idade , Miocardite/diagnóstico por imagem , Miocardite/terapia , Peru , Projetos Piloto , Fatores de Tempo , Vasculite/diagnóstico por imagem , Vasculite/terapia , Adulto Jovem
2.
J Pediatr ; 183: 108-114.e1, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28189300

RESUMO

OBJECTIVES: To examine the associations of macular pigment carotenoids (lutein, meso-zeaxanthin, and zeaxanthin), aerobic fitness, and central adiposity with hippocampal-dependent relational memory in prepubescent children. STUDY DESIGN: Children between 7 and 10 years of age (n = 40) completed a task designed to assess relational memory performance and participated in aerobic fitness, adiposity, and macular pigment optical density (MPOD) assessment. Aerobic fitness was assessed via a modified Balke treadmill protocol designed to measure maximal oxygen volume. Central adiposity was assessed via dual-energy x-ray absorptiometry. MPOD was measured psychophysically by the use of customized heterochromatic flicker photometry. Statistical analyses included correlations and hierarchical linear regression. RESULTS: Aerobic fitness and MPOD were associated negatively with relational memory errors (P < .01), whereas central adiposity was associated positively with relational memory errors (P < .05). Hierarchical regression analysis revealed that MPOD accounted for a significant amount of the variance in relational memory performance even after we accounted for aerobic fitness (ß = -0.388, P = .007). CONCLUSIONS: Even after we adjusted for aerobic fitness and central adiposity, factors known to relate to hippocampal-dependent memory, MPOD positively and significantly predicted hippocampal-dependent memory performance. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01619826.


Assuntos
Carotenoides/metabolismo , Hipocampo/metabolismo , Macula Lutea/metabolismo , Transtornos da Memória/diagnóstico , Obesidade Abdominal/diagnóstico , Aptidão Física/fisiologia , Fatores Etários , Biomarcadores/metabolismo , Criança , Estudos de Coortes , Feminino , Hipocampo/fisiologia , Humanos , Luteína/metabolismo , Masculino , Memória/fisiologia , Transtornos da Memória/metabolismo , Fotometria , Estudos Prospectivos , Análise de Regressão , Sensibilidade e Especificidade , Zeaxantinas/metabolismo
3.
Mol Biochem Parasitol ; 183(2): 166-76, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22449941

RESUMO

The rate of treatment failure to antileishmanial chemotherapy in Latin America is up to 64%. Parasite drug resistance contributes to an unknown proportion of treatment failures. Identification of clinically relevant molecular mechanisms responsible for parasite drug resistance is critical to the conservation of available drugs and to the discovery of novel targets to reverse the resistant phenotype. We conducted comparative proteomic-based analysis of Leishmania (Viannia) panamensis lines selected in vitro for resistance to trivalent antimony (Sb(III)) to identify factors associated with antimony resistance. Using 2-dimensional gel electrophoresis, two distinct sub-proteomes (soluble in NP-40/urea and Triton X-114, respectively) of promastigotes of WT and Sb(III)-resistant lines were generated. Overall, 9 differentially expressed putative Sb-resistance factors were detected and identified by mass spectrometry. These constituted two major groups: (a) proteins involved in general stress responses and (b) proteins with highly specific metabolic and transport functions, potentially directly contributing to the Sb-resistance mechanism. Notably, the sulfur amino acid-metabolizing enzymes S-adenosylmethionine synthetase (SAMS) and S-adenosylhomocysteine hydrolase (SAHH) were over-expressed in Sb(III)-resistant lines and Sb(III)-resistant clinical isolates. These enzymes play a central role in the upstream synthesis of precursors of trypanothione, a key molecule involved in Sb-resistance in Leishmania parasites, and suggest involvement of epigenetic regulation in response to drug exposure. These data re-enforce the importance of thiol metabolism in Leishmania Sb resistance, reveal previously unrecognized steps in the mechanism(s) of Sb tolerance, and suggest a cross-talk between drug resistance, metabolism and virulence.


Assuntos
Antimônio/farmacologia , Antiprotozoários/farmacologia , Resistência Microbiana a Medicamentos , Leishmania guyanensis/química , Leishmania guyanensis/efeitos dos fármacos , Proteoma/análise , Proteínas de Protozoários/metabolismo , Adenosil-Homocisteinase/isolamento & purificação , Adenosil-Homocisteinase/metabolismo , Eletroforese em Gel Bidimensional , Expressão Gênica , Glutationa/análogos & derivados , Glutationa/biossíntese , Humanos , América Latina , Espectrometria de Massas , Metionina Adenosiltransferase/isolamento & purificação , Metionina Adenosiltransferase/metabolismo , Proteínas de Protozoários/isolamento & purificação , Espermidina/análogos & derivados , Espermidina/biossíntese
4.
Proc Natl Acad Sci U S A ; 107(46): 20045-50, 2010 Nov 16.
Artigo em Inglês | MEDLINE | ID: mdl-21037109

RESUMO

Plasmodium vivax causes 25-40% of malaria cases worldwide, yet research on this human malaria parasite has been neglected. Nevertheless, the recent publication of the P. vivax reference genome now allows genomics and systems biology approaches to be applied to this pathogen. We show here that whole-genome analysis of the parasite can be achieved directly from ex vivo-isolated parasites, without the need for in vitro propagation. A single isolate of P. vivax obtained from a febrile patient with clinical malaria from Peru was subjected to whole-genome sequencing (30× coverage). This analysis revealed over 18,261 single-nucleotide polymorphisms (SNPs), 6,257 of which were further validated using a tiling microarray. Within core chromosomal genes we find that one SNP per every 985 bases of coding sequence distinguishes this recent Peruvian isolate, designated IQ07, from the reference Salvador I strain obtained in 1972. This full-genome sequence of an uncultured P. vivax isolate shows that the same regions with low numbers of aligned sequencing reads are also highly variable by genomic microarray analysis. Finally, we show that the genes containing the largest ratio of nonsynonymous-to-synonymous SNPs include two AP2 transcription factors and the P. vivax multidrug resistance-associated protein (PvMRP1), an ABC transporter shown to be associated with quinoline and antifolate tolerance in Plasmodium falciparum. This analysis provides a data set for comparative analysis with important potential for identifying markers for global parasite diversity and drug resistance mapping studies.


Assuntos
Resistência a Medicamentos/genética , Genes de Protozoários/genética , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Plasmodium vivax/genética , Seleção Genética , Análise de Sequência de DNA/métodos , Eritrócitos/parasitologia , Regulação da Expressão Gênica , Humanos , Leucócitos/parasitologia , Vacinas Antimaláricas/imunologia , Família Multigênica/genética , Mutação/genética , Peru , Plasmodium vivax/imunologia , Plasmodium vivax/isolamento & purificação , Polimorfismo Genético , Alinhamento de Sequência , Fatores de Transcrição/genética
5.
Environ Sci Technol ; 44(5): 1617-23, 2010 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-20131822

RESUMO

The production of nitrous oxide (N(2)O), a potent greenhouse gas, in hypoxic coastal zones remains poorly characterized due to a lack of data, though large nitrogen inputs and deoxygenation typical of these systems create the potential for large N(2)O emissions. We report the first N(2)O emission measurements from the Gulf of Mexico Hypoxic Zone (GOMHZ), including an estimate of the emission "pulse" associated with the passage of Tropical Storm Edouard in August, 2008. Prestorm emission rates (25-287 nmol m(-2) hr(-1)) and dissolved N(2)O concentrations (5 - 30 nmol L(-1)) were higher than values reported for the Caribbean and western Tropical Atlantic, and on the lower end of the range of observations from deeper coastal hypoxic zones. During the storm, N(2)O rich subsurface water was mixed upward, increasing average surface concentrations and emission rates by 23% and 61%, respectively. Approximately 20% of the N(2)O within the water column vented to the atmosphere during the storm, equivalent to 13% of the total "hypoxia season" emission. Relationships between N(2)O, NO(3)(-), and apparent oxygen utilization (AOU) suggest enhanced post storm N(2)O production, most likely in response to reoxygenation of the water column and redistribution of organic nitrogen. Our results indicate that mixing related emissions contribute significantly to total seasonal emissions and must therefore be included in emission models and inventories for the GOMHZ and other shallow coastal hypoxic zones.


Assuntos
Poluentes Atmosféricos/análise , Óxido Nitroso/análise , Poluentes Químicos da Água/análise , Região do Caribe , Clima , Monitoramento Ambiental/métodos , Efeito Estufa/estatística & dados numéricos , Hipóxia , Louisiana , Óxidos de Nitrogênio/análise , Oceanos e Mares , Salinidade , Temperatura , Texas , Vento
6.
Rev Panam Salud Publica ; 26(1): 55-63, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19814883

RESUMO

OBJECTIVE: To determine the per patient and overall cost of illness of type 2 diabetes mellitus (T2DM) in Colombia from Ministry of Health and societal perspectives. METHODS: A published Markov transition model was adapted for Colombia, using the clinical expertise of a Colombian endocrinologist. Transition probabilities for the model were derived from an international literature review. A model was run for a time horizon of 42 years. Direct resources (drugs, laboratory, medical, hospital, other health care) were identified and cost was ascertained by using national price lists, international health care guidelines, and other Colombian studies or data from other countries. Indirect costs (work time lost) were calculated by using the human capital approach. Annual and lifetime direct and indirect costs, in 2007 U.S. dollars with a 5% discount rate, were determined on a per patient basis and projected to the overall Colombian population. Costs were clustered according to treatments and outcomes. RESULTS: The estimated annual cost was $2.7 billion from the societal perspective and $921 million from the Ministry of Health perspective. The annual direct cost per patient was $288, and the indirect cost was $559 (total = $847). This cost was distributed across disease outcomes as follows: diabetes treatment (drugs), 47%; cardiac and coronary disease, 24%; stroke, 15%; amputation, 9%; nephropathy, 3%; retinopathy, 2%. Macrovascular complications made up 86% of the annual direct costs and 95% of the annual indirect costs of T2DM. CONCLUSIONS: We estimated the annual cost of T2DM for Colombia from societal, Ministry of Health, and Colombian Health System perspectives. We also estimated annual direct cost per patient and the cost of treating diabetes and macrovascular complications. The economic burden is substantial and comparable to results for other countries. The model showed a logical disease progression.


Assuntos
Efeitos Psicossociais da Doença , Diabetes Mellitus Tipo 2/economia , Colômbia , Humanos
7.
Rev. panam. salud pública ; 26(1): 55-63, jul. 2009. ilus, graf, tab
Artigo em Inglês | LILACS | ID: lil-525129

RESUMO

OBJECTIVE: To determine the per patient and overall cost of illness of type 2 diabetes mellitus (T2DM) in Colombia from Ministry of Health and societal perspectives. METHODS: A published Markov transition model was adapted for Colombia, using the clinical expertise of a Colombian endocrinologist. Transition probabilities for the model were derived from an international literature review. A model was run for a time horizon of 42 years. Direct resources (drugs, laboratory, medical, hospital, other health care) were identified and cost was ascertained by using national price lists, international health care guidelines, and other Colombian studies or data from other countries. Indirect costs (work time lost) were calculated by using the human capital approach. Annual and lifetime direct and indirect costs, in 2007 U.S. dollars with a 5 percent discount rate, were determined on a per patient basis and projected to the overall Colombian population. Costs were clustered according to treatments and outcomes. RESULTS: The estimated annual cost was $2.7 billion from the societal perspective and $921 million from the Ministry of Health perspective. The annual direct cost per patient was $288, and the indirect cost was $559 (total = $847). This cost was distributed across disease outcomes as follows: diabetes treatment (drugs), 47 percent; cardiac and coronary disease, 24 percent; stroke, 15 percent; amputation, 9 percent; nephropathy, 3 percent; retinopathy, 2 percent. Macrovascular complications made up 86 percent of the annual direct costs and 95 percent of the annual indirect costs of T2DM. CONCLUSIONS: We estimated the annual cost of T2DM for Colombia from societal, Ministry of Health, and Colombian Health System perspectives. We also estimated annual direct cost per patient and the cost of treating diabetes and macrovascular complications. The economic burden is substantial and comparable to results for other countries. The model showed a logical ...


OBJETIVO: Determinar el costo de la enfermedad, total y por paciente, de la diabetes mellitus tipo 2 (DM2) en Colombia desde las perspectivas de la sociedad y del Ministerio de Salud. MÉTODOS: A partir de la experiencia clínica de un endocrinólogo colombiano se adaptó para Colombia un modelo de transición de Markov ya publicado. Las probabilidades de transición para el modelo se tomaron de una revisión de la literatura internacional. Se elaboró un modelo para un horizonte temporal de 42 años. Se identificaron los recursos directos (por medicamentos, laboratorio, médicos, hospitalización y otros servicios de salud) y se estableció su costo a partir de la lista nacional de precios, las directivas internacionales de atención, y otros estudios colombianos o de otros países. Los costos indirectos (tiempo de trabajo perdido) se calculó mediante el enfoque de capital humano. Los costos directos e indirectos -tanto anuales como por toda la vida- se determinaron en dólares estadounidenses (US$) de 2007 con una tasa de descuento de 5 por ciento, tanto para un paciente como su proyección para toda la población colombiana. Los costos se agruparon según el tratamiento y el curso de la enfermedad. RESULTADOS: El costo estimado anual fue de US$ 2 700 millones desde la perspectiva de la sociedad y de US$ 921 millones desde la perspectiva del Ministerio de Salud. Los costos directos anuales por paciente fueron de US$ 288, mientras que los indirectos fueron US$ 559 (total = US$ 847). Estos costos se distribuyeron según el curso de la enfermedad de la siguiente manera: 47 por ciento por el tratamiento de la diabetes (medicamentos); 24 por ciento por enfermedades cardíacas y coronarias; 15 por ciento por accidentes cerebrovasculares; 9 por ciento por amputaciones; 3 por ciento por nefropatías; y 2 por ciento por retinopatías. Las complicaciones macrovasculares constituyeron 86 por ciento de los costos directos anuales y 95 por ciento de los indirectos. CONCLUSIONES: ...


Assuntos
Humanos , Efeitos Psicossociais da Doença , /economia , Colômbia
9.
Norfolk; Humana Press; 3rd ed; 2009. xxxv, 1985 p. ilus, tab.(Springer protocols handbooks).
Monografia em Inglês | Sec. Est. Saúde SP, SESSP-IBACERVO | ID: biblio-1075502
10.
Antimicrob Agents Chemother ; 52(12): 4503-6, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18824610

RESUMO

The participation of trypanothione in clinical and experimental antimony (Sb) resistance in Leishmania panamensis was examined by using specific inhibitors. Buthionine sulfoximine (BSO) significantly reversed the resistance to trivalent Sb (Sb(III)) of promastigotes of experimentally derived Sb-resistant lines, supporting the participation of a trypanothione-mediated mechanism of resistance. In contrast, promastigotes of strains isolated at the time of clinical treatment failure and resistant to pentavalent Sb (Sb(V)) as intracellular amastigotes were not cross resistant to Sb(III), and BSO had little or no effect on susceptibility. Difluoromethylornithine did not alter the Sb(III) susceptibilities of experimentally selected lines or clinical strains. The mechanisms of acquired resistance emerging in clinical settings may differ from those selected by in vitro exposure to Sb.


Assuntos
Antimônio/farmacologia , Antiprotozoários/farmacologia , Resistência a Medicamentos , Glutationa/análogos & derivados , Leishmania/efeitos dos fármacos , Leishmaniose/parasitologia , Espermidina/análogos & derivados , Animais , Butionina Sulfoximina/farmacologia , Glutationa/metabolismo , Humanos , Leishmania/classificação , Leishmania/crescimento & desenvolvimento , Leishmania/metabolismo , Leishmaniose/tratamento farmacológico , Testes de Sensibilidade Parasitária , Espermidina/metabolismo
11.
Environ Pollut ; 154(1): 143-54, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18407389

RESUMO

The small watershed approach is well-suited but underutilized in mercury research. We applied the small watershed approach to investigate total mercury (THg) and methylmercury (MeHg) dynamics in streamwater at the five diverse forested headwater catchments of the US Geological Survey Water, Energy, and Biogeochemical Budgets (WEBB) program. At all sites, baseflow THg was generally less than 1ng L(-1) and MeHg was less than 0.2ng L(-1). THg and MeHg concentrations increased with streamflow, so export was primarily episodic. At three sites, THg and MeHg concentration and export were dominated by the particulate fraction in association with POC at high flows, with maximum THg (MeHg) concentrations of 94 (2.56)ng L(-1) at Sleepers River, Vermont; 112 (0.75)ng L(-1) at Rio Icacos, Puerto Rico; and 55 (0.80)ng L(-1) at Panola Mt., Georgia. Filtered (<0.7microm) THg increased more modestly with flow in association with the hydrophobic acid fraction (HPOA) of DOC, with maximum filtered THg concentrations near 5ng L(-1) at both Sleepers and Icacos. At Andrews Creek, Colorado, THg export was also episodic but was dominated by filtered THg, as POC concentrations were low. MeHg typically tracked THg so that each site had a fairly constant MeHg/THg ratio, which ranged from near zero at Andrews to 15% at the low-relief, groundwater-dominated Allequash Creek, Wisconsin. Allequash was the only site with filtered MeHg consistently above detection, and the filtered fraction dominated both THg and MeHg. Relative to inputs in wet deposition, watershed retention of THg (minus any subsequent volatilization) was 96.6% at Allequash, 60% at Sleepers, and 83% at Andrews. Icacos had a net export of THg, possibly due to historic gold mining or frequent disturbance from landslides. Quantification and interpretation of Hg dynamics was facilitated by the small watershed approach with emphasis on event sampling.


Assuntos
Monitoramento Ambiental/métodos , Mercúrio/análise , Compostos de Metilmercúrio/análise , Rios , Poluentes Químicos da Água/análise , Carbono , Colorado , Georgia , Substâncias Húmicas , Material Particulado , Porto Rico , Solubilidade , Espectrofotometria Atômica , Tempo , Árvores , Vermont , Movimentos da Água , Wisconsin
12.
Exp Parasitol ; 116(4): 475-82, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17466980

RESUMO

Certain model inhibitors exerted selective action against the catalytic activity of nuclear DNA topoisomerase II (TOPII) of Leishmania panamensis promastigotes. The second-generation fluoroquinolones enoxacin and ciprofloxacin exhibited extraordinarily high anti-parasite selectivity displaying 582- and 40-fold greater potencies against L. panamensis TOPII as compared with the human macrophage enzyme. The flavonoids quercetin and ellagic acid showed inverse specificities, the former being 161-fold more potent against L. panamensis TOPII, and the latter 15.7-fold more active against macrophage TOPII. The protoberberine coralyne was a potent inhibitor of both Leishmania and macrophage TOPII. Bis-benzimidazoles and the diamidine diminazene aceturate exhibited uniformly high potencies against parasite and host TOPII, but a second diamidine pentamidine showed 17.6-fold greater specificity for Leishmania TOPII. The antimonial sodium stibogluconate was an ineffective inhibitor of parasite TOPII showing 4.3-fold greater potency against the macrophage enzyme. These findings suggest that the leishmanicidal activities of certain fluoroquinolones and pentamidine may be mediated partly through TOPII inhibition.


Assuntos
Anti-Infecciosos/farmacologia , Flavonoides/farmacologia , Fluoroquinolonas/farmacologia , Leishmania guyanensis/enzimologia , Pentamidina/farmacologia , Inibidores da Topoisomerase II , Animais , Antiprotozoários/farmacologia , Linhagem Celular , Núcleo Celular/enzimologia , Ciprofloxacina/farmacologia , Ácido Elágico/farmacologia , Enoxacino/farmacologia , Humanos , Concentração Inibidora 50 , Leishmania guyanensis/efeitos dos fármacos , Macrófagos/enzimologia , Quercetina/farmacologia
13.
J Neurochem ; 101(1): 27-40, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17241119

RESUMO

In contrast to mammals, salamanders have a remarkable ability to regenerate their spinal cord and recover full movement and function after tail amputation. To identify genes that may be associated with this greater regenerative ability, we designed an oligonucleotide microarray and profiled early gene expression during natural spinal cord regeneration in Ambystoma mexicanum. We sampled tissue at five early time points after tail amputation and identified genes that registered significant changes in mRNA abundance during the first 7 days of regeneration. A list of 1036 statistically significant genes was identified. Additional statistical and fold change criteria were applied to identify a smaller list of 360 genes that were used to describe predominant expression patterns and gene functions. Our results show that a diverse injury response is activated in concert with extracellular matrix remodeling mechanisms during the early acute phase of natural spinal cord regeneration. We also report gene expression similarities and differences between our study and studies that have profiled gene expression after spinal cord injury in rat. Our study illustrates the utility of a salamander model for identifying genes and gene functions that may enhance regenerative ability in mammals.


Assuntos
Ambystoma/genética , Regulação da Expressão Gênica/genética , Regeneração Nervosa/genética , Plasticidade Neuronal/genética , Traumatismos da Medula Espinal/genética , Medula Espinal/fisiologia , Ambystoma/anatomia & histologia , Animais , Regulação para Baixo/genética , Proteínas da Matriz Extracelular/biossíntese , Proteínas da Matriz Extracelular/genética , Perfilação da Expressão Gênica , Proteínas do Tecido Nervoso/biossíntese , Proteínas do Tecido Nervoso/genética , Neurônios/citologia , Neurônios/fisiologia , Análise de Sequência com Séries de Oligonucleotídeos , RNA Mensageiro/análise , RNA Mensageiro/metabolismo , Ratos , Especificidade da Espécie , Medula Espinal/citologia , Células-Tronco/citologia , Células-Tronco/fisiologia , Regulação para Cima/genética
14.
J Infect Dis ; 194(4): 503-11, 2006 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-16845635

RESUMO

BACKGROUND: American cutaneous leishmaniasis is considered to be a zoonotic disease transmitted by sand flies that feed on infected sylvatic mammals. However, the "domestication" of transmission and the increase in treatment failure with antimonial drugs have raised the suspicion of anthroponotic transmission of American cutaneous leishmaniasis. METHODS: The objective of the present study was to explore the potential of humans as a source of infection for sand flies. Biological (xenodiagnosis and culture) and molecular (polymerase chain reaction/Southern blot) detection methods were used to evaluate peripheral-blood monocytes and tissue fluids from sites accessible to sand flies from 59 adult patients with parasitologically confirmed American cutaneous leishmaniasis. RESULTS: Overall, 44.1% of patients (26/59) presented biological and/or molecular evidence of Leishmania parasites in normal skin, peripheral-blood monocytes, lesion scars, or lesion border (by xenodiagnosis) before (18/59 [30.5%]) or after (10/27 [37.0%]) treatment. Leishmania parasites were cultured from the unaffected skin of 2 (3.6%) of 55 patients, and xenodiagnosis gave positive results for 5 (8.8%) of 57 patients before treatment. CONCLUSIONS: The presence of Leishmania parasites in the unaffected skin and peripheral-blood monocytes of a high proportion of patients even after treatment and the acquisition of infection by sand flies support the plausibility of anthroponotic transmission of American cutaneous leishmaniasis.


Assuntos
Reservatórios de Doenças , Leishmania/isolamento & purificação , Leishmaniose Cutânea/parasitologia , Leishmaniose Cutânea/transmissão , Adolescente , Adulto , Animais , Antiprotozoários/uso terapêutico , Cicatriz/parasitologia , DNA de Protozoário/análise , Feminino , Humanos , Insetos Vetores/parasitologia , Leishmaniose Cutânea/tratamento farmacológico , Leucócitos Mononucleares/parasitologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Psychodidae/parasitologia , Pele/parasitologia
15.
Mol Biochem Parasitol ; 147(1): 64-73, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16530278

RESUMO

We have employed proteomics to identify proteins upregulated in the amastigote life-stage of Leishmaniapanamensis, using axenically-differentiated forms as models of authentic intracellular parasites. Resolution of the soluble proteomes of axenic amastigotes and promastigotes by two-dimensional electrophoresis (2DE) in the neutral pI range (5-7) revealed equivalent numbers of protein spots in both life-stages (644-682 using Coomassie Blue and 851-863 by silver staining). Although representing a relatively low proportion (8.1-10.8%) of the predicted 8000 gene products of Leishmania, these proteome maps enabled the reproducible detection of 75 differentially-regulated protein spots in amastigotes, comprising 24 spots "uniquely" expressed in this life-stage and 51 over-expressed by 1.2-5.7-fold compared to promastigotes. Of the 11 amastigote-specific spots analysed by mass spectrometry (MS), 5 yielded peptide sequences with no orthologues in Leishmania major, and the remaining 6 were identified as 7 distinct proteins (some of which were truncated isoforms) representing several functional classes: carbohydrate/energy metabolism (fructose 1,6-bisphosphate aldolase, glucose 6-phosphate dehydrogenase, pyruvate dehydrogenase), stress response (heat shock protein [HSP] 83), cell membrane/cytoskeleton (beta-tubulin), amino acid metabolism (cysteine synthase) and cell-cycle (ran-binding protein). Four additional over-expressed spots were tentatively identified as HSPs 60 and 70 and HSP 70-related proteins -1 and -4 by positional analogy with these landmark proteins in the Leishmania guyanensis proteome. Our data demonstrate the feasibility of proteomics as an approach to identify novel developmentally-regulated proteins linked to Leishmania differentiation and intracellular survival, while simultaneously pinpointing therapeutic targets. In particular, the amastigote-specific expression of cysteine synthase underlines the importance of de novo cysteine synthesis both as a potential parasite virulence factor and as a major metabolic difference from mammalian host cells.


Assuntos
Perfilação da Expressão Gênica , Regulação da Expressão Gênica no Desenvolvimento , Leishmania/crescimento & desenvolvimento , Proteoma , Proteínas de Protozoários/metabolismo , Sequência de Aminoácidos , Animais , Eletroforese em Gel Bidimensional , Leishmania/genética , Leishmania/metabolismo , Espectrometria de Massas , Dados de Sequência Molecular , Proteínas de Protozoários/genética
16.
Exp Parasitol ; 112(1): 21-30, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16293247

RESUMO

Different classes of topoisomerase (TOP) inhibitors and antitrypanosomatid agents exhibited variable efficacies against Leishmania donovani parasites and human mononuclear cells both at the level of DNA topoisomerase I (TOPI) catalytic activity and in cytotoxicity assays. Bis-benzimidazoles and the diamidine diminazene aceturate exhibited uniformly high efficacies against parasite and host enzymes as well as against parasite and mononuclear cells, but pentamidine showed around 2 orders of magnitude greater specificity for Leishmania TOPI and amastigote cells (P<0.05). The protoberberine coralyne and the flavonoid quercetin were highly potent, but non-selective, inhibitors in vitro, although the latter showed slight selectivity for parasite TOPI. Camptothecin was selective for mononuclear cells at both levels (P<0.05) and sodium stibogluconate was selective only at the enzyme level displaying 30-fold greater potency against parasite TOPI (P<0.05). These data suggest that at least part of pentamidines' leishmanicidal activity may be mediated through TOPI inhibition, and support the feasibility of exploiting differences between Leishmania and human TOPs to develop modified compounds with improved selectivity.


Assuntos
Antiprotozoários/farmacologia , Inibidores Enzimáticos/farmacologia , Leishmania donovani/efeitos dos fármacos , Monócitos/parasitologia , Inibidores da Topoisomerase I , Fosfatase Ácida/análise , Animais , Gluconato de Antimônio e Sódio/farmacologia , Benzimidazóis/farmacologia , Alcaloides de Berberina/farmacologia , Bisbenzimidazol/farmacologia , Camptotecina/farmacologia , Linhagem Celular , DNA Topoisomerases Tipo I/metabolismo , Diminazena/análogos & derivados , Diminazena/farmacologia , Relação Dose-Resposta a Droga , Humanos , Concentração Inibidora 50 , Luciferases de Vaga-Lume/genética , Substâncias Luminescentes , Macrófagos/efeitos dos fármacos , Macrófagos/enzimologia , Monócitos/efeitos dos fármacos , Monócitos/enzimologia , Pentamidina/farmacologia , Quercetina/farmacologia
17.
Mol Biochem Parasitol ; 145(2): 254-64, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16325936

RESUMO

Parasites of the Leishmania Viannia subgenus are major causative agents of mucocutaneous leishmaniasis (MCL), a disease characterised by parasite dissemination (metastasis) from the original cutaneous lesion to form debilitating secondary lesions in the nasopharyngeal mucosa. We employed a protein profiling approach to identify potential metastasis factors in laboratory clones of L. (V.) guyanensis with stable phenotypes ranging from highly metastatic (M+) through infrequently metastatic (M+/M-) to non-metastatic (M-). Comparison of the soluble proteomes of promastigotes by two-dimensional electrophoresis revealed two abundant protein spots specifically associated with M+ and M+/M- clones (Met2 and Met3) and two others exclusively expressed in M- parasites (Met1 and Met4). The association between clinical disease phenotype and differential expression of Met1-Met4 was less clear in L. Viannia strains from mucosal (M+) or cutaneous (M-) lesions of patients. Identification of Met1-Met4 by biological mass spectrometry (LC-ES-MS/MS) and bioinformatics revealed that M+ and M- clones express distinct acidic and neutral isoforms of both elongation factor-1 subunit beta (EF-1beta) and cytosolic tryparedoxin peroxidase (TXNPx). This interchange of isoforms may relate to the mechanisms by which the activities of EF-1beta and TXNPx are modulated, and/or differential post-translational modification of the gene product(s). The multiple metabolic functions of EF-1 and TXNPx support the plausibility of their participation in parasite survival and persistence and thereby, metastatic disease. Both polypeptides are active in resistance to chemical and oxidant stress, providing a basis for further elucidation of the importance of antioxidant defence in the pathogenesis underlying MCL.


Assuntos
Regulação da Expressão Gênica , Leishmania guyanensis/química , Fator 1 de Elongação de Peptídeos/análise , Peroxidases/análise , Proteoma/análise , Proteínas de Protozoários/análise , Sequência de Aminoácidos , Animais , Biologia Computacional , DNA de Protozoário , Eletroforese em Gel Bidimensional , Immunoblotting , Leishmania guyanensis/genética , Leishmania guyanensis/crescimento & desenvolvimento , Espectrometria de Massas , Dados de Sequência Molecular , Isoformas de Proteínas/análise , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos
18.
Am J Trop Med Hyg ; 72(4): 423-9, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15827280

RESUMO

We evaluated the Leishmania Viannia-specific primers B1-B2 to detect Leishmania in normal skin and peripheral blood monocytes of patients with active cutaneous leishmaniasis. Southern blotting and sequencing of polymerase chain reaction (PCR) products confirmed the specificity of kinetoplast DNA (kDNA) amplification from tissue fluid from healthy skin, whereas the PCR with monocytes also amplified a human sequence of a size similar (718 basepairs) to the expected kDNA product (750 basepairs), resulting in false-positive results. Although B1 was not homologous to any human DNA sequence, B2 showed homology to a human chromosome 2 intergenic region (AC010878) at positions 35,881-36,599, which are spaced 718 nucleotides apart. Amplification of the human artifact from monocyte DNA was confirmed using the primer B2 alone. Examination of other primers reported for the PCR of kDNA from various species of Leishmania showed that six of seven were homologous to human DNA sequences. These findings underscore the importance of exploiting sequencing, bioinformatics, and DNA probes to refine molecular amplification techniques and to validate the performance of primers when used for new applications.


Assuntos
Primers do DNA , DNA de Cinetoplasto/genética , DNA/genética , Genoma de Protozoário , Leishmania/isolamento & purificação , Animais , Southern Blotting , Criança , Pré-Escolar , Clonagem Molecular , Colômbia , Humanos , Leishmania/genética , Reação em Cadeia da Polimerase
19.
J Parasitol ; 91(6): 1474-9, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16539034

RESUMO

We have demonstrated that fluoroquinolones, a class of antibacterial agents that act through inhibition of type II DNA topoisomerases, exert selective action against intracellular amastigotes of Leishmania (Viannia) panamensis at concentrations that are achievable in vivo. Drug cytotoxicity assays employing the luciferase reporter gene revealed that intracellular amastigotes were 6.6- to 25.9-fold more sensitive than human macrophages (P < 0.05) to second-generation fluoroquinolones in vitro. The most selective agents (enoxacin and ciprofloxacin) exhibited 2 orders of magnitude greater potency against parasites (50% effective dose [ED50] = 54.9-83.4 microM) than host cells (ED50 = 1,425-1,740 microM). Linear regression analysis of ED50 data confirmed a complete lack of correlation (r = 0.001) between the relative drug sensitivities of parasites and host cells. A potential relationship between the structures of fluoroquinolones and their relative leishmanicidal activities was observed. The key substituents of the basic pyridone beta-carboxylic acid nucleus accounting for enhanced antiparasite potency and selectivity appear to be a nitrogen at position 8 of the bicyclic nucleus (enoxacin), a cyclopropyl substituent at the R1 site (ciprofloxacin), and linkage of the R1 and X8 groups by a CH3CHO bridge to form a tricyclic compound (ofloxacin). These findings support the potential of fluoroquinolones and derivatives as novel antileishmanials and encourage their clinical evaluation.


Assuntos
Fluoroquinolonas/farmacologia , Leishmania guyanensis/efeitos dos fármacos , Macrófagos/parasitologia , Animais , Linhagem Celular , Cinoxacino/farmacologia , Ciprofloxacina/farmacologia , Enoxacino/farmacologia , Humanos , Macrófagos/efeitos dos fármacos , Ácido Nalidíxico/farmacologia , Norfloxacino/farmacologia , Ofloxacino/farmacologia , Quinolonas/farmacologia
20.
Biomédica (Bogotá) ; Biomédica (Bogotá);24(4): 438-455, dic. 2004. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-422508

RESUMO

Durante los últimos 15 años se ha dado paso al entendimiento de muchos aspectos de la genómica funcional de Leishmania gracias a los avances en la metodología de transfección de ADN dentro de la célula de este protozoario, la eliminación y la complementación de genes por medio de recombinación homóloga y las estrategias para la selección de células transfectadas. Estos acercamientos tienen el potencial de brindar información sobre la expresión génica y la función de las proteínas en el contexto del parásito intacto. Dado que el genoma de Leishmania muestra una carencia acentuada de los factores conocidos de iniciación de la transcripción y que la expresión génica está regulada casi completamente a nivel postranscripcional (a través del empalme de los ARNm y los mecanismos que involucran el procesamiento diferencial de la región no traducida 3' del ARNm (3'UTR), la transfección génica representa una herramienta útil para la identificación y el análisis funcional de los genes de interés así como de los mecanismos que dirigen su regulación. El desarrollo de los sistemas de manipulación genética también ha abierto nuevos horizontes para la identificación de genes esenciales involucrados en la virulencia, la supervivencia intracelular y la resistencia a drogas de Leishmania, así como para la validación de proteínas específicas del parásito como nuevos blancos quimio e inmunoterapéuticos. En esta revisión presentamos los avances más recientes en el campo de la manipulación genética en Leishmania, los cuales permiten análisis estructurales, funcionales y de fenotipo, por medio de la eliminación y complementación génica a través de la transfección transitoria o permanente de genes en este parásito


Assuntos
Expressão Gênica , Leishmania/genética , Transfecção , Transformação Genética , Teste de Complementação Genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA